Evaluating Investigational Drug PLN-74809 in Participants with Primary

Build status - In Progress

Recruiting

18 years - 75 years

All

Phase 2

5 participants needed

1 Location

Brief description of study

The purpose of this study is to determine the safety and tolerability of an experimental medication PLN-74809 to treat primary Sclerosing Cholangitis (PSC), a rare, long-term liver disease affecting the bile ducts (small tubes) inside and outside the liver. Participants will visit the study center 8 times within 22 weeks. Compensation maximum amount you will be paid is $700.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Sclerosing Cholangitis, PSC, liver
Age: 18 years - 75 years
Gender: All

Updated on 04 Aug 2024. Study ID: 843393

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.